Leonard D'Amico

Research Staff
Research Scientist

Leonard received his PhD from the Zoology Department at the University of Washington in 2001, where he studied the early development of Zebrafish embryos.  During his Post-doctoral work at the University of California, San Francisco, he explored the molecular genetics of early Zebrafish heart development.  Before joining the Tumor Vaccine Group, Leonard worked as a staff scientist at the Benaroya Research Institute, where he worked on developing a novel implant device to treat a mouse model of Diabetes, as well as, explored the molecular genetics of T cell differentiation in relation to autoimmune disease.  His current research interests at the TVG include measuring patient T cell immune response to cancer vaccines, and exploring the mechanisms and targets of vaccine-induced epitope spreading in breast cancer patients and its relation to clinical response.